Delivery Order SPE2DR25D1021-SPE2DR26FNN8B
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,473.70 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on December 9, 2025, with completion scheduled for December 10, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $10,855.22 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed price, non-set-aside contract is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $4,775.88 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed price delivery order represents a non-competitive set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $3,183.92 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on December 11, 2025, with completion targeted for December 12, 2025. This contract represents a firm fixed price delivery against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made on a competitive basis without set-aside designation, reflecting the vendor's established capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,441.44 to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. This firm fixed-price delivery order, with an ultimate completion date of November 13, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $26,327.14 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on December 10, 2025, with a completion date of December 11, 2025. This contract represents a firm fixed-price delivery order under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor supporting federal medical procurement needs, particularly for military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.95 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this contract. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,828.41 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of HUMIRA (adalimumab) prefilled pens containing 40 mg/0.4 mL doses. This is a firm fixed-price, non-set-aside contract with a completion date of December 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for supply of HUMIRA (CF) Pen 40 mg/0.4 mls with a ceiling value of $30,231.93. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill the performance...
- The Defense Logistics Agency awarded a $1,959.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL on December 8, 2025, with completion targeted for December 9, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The contract will be performed at...
- SPE2DR25D1021Indefinite Delivery Contract
- SPE2DR25D1021-SPE2DR26FNN8BDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,387.94 on December 1, 2025, for HUMIRA (CF) Pen 40 mg/0.4 mL, with an ultimate completion date of December 2, 2025. This is a firm fixed price, non-set-aside contract to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. As a competitively awarded contractor, the company demonstrates capability across a diverse portfolio of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for HUMIRA, a rheumatoid arthritis treatment, represents one of numerous small-value transactions the contractor fulfills through its DLA prime contract vehicle, supporting the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 11/30/25 |